3M, Visa, Medtronic And More On CNBC's 'Final Trades'
Portfolio Pulse from Avi Kapoor
On CNBC's 'Final Trades', analysts discussed 3M, Visa, Medtronic, and Invesco S&P 500 High Dividend Low Volatility ETF. 3M was rated Underweight by Morgan Stanley, Visa received a Buy rating from Compass Point, Medtronic reported strong earnings, and Invesco ETF was highlighted for its dividend yield.
September 11, 2024 | 12:16 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
3M was discussed on CNBC's 'Final Trades' with a recent Underweight rating from Morgan Stanley and a price target of $125. The stock gained 1.3% to close at $130.09.
3M's recent gain contrasts with Morgan Stanley's Underweight rating, suggesting mixed investor sentiment. The stock's current price is above the target, indicating potential downward pressure.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEUTRAL IMPACT
Invesco S&P 500 High Dividend Low Volatility ETF was mentioned for its dividend yield, rising 0.2% during the session.
The ETF's focus on high dividends and low volatility makes it attractive for income-focused investors, but the impact on price is minimal.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Medtronic reported strong Q1 earnings, beating expectations with $7.92 billion in sales and an EPS of $1.23. The stock rose 0.4% to $90.99.
Medtronic's better-than-expected earnings and revenue growth support a positive short-term outlook, reflected in the stock's slight increase.
CONFIDENCE 95
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Visa was highlighted with a Buy rating from Compass Point and a price target of $319. The stock fell 0.1% to $285.34.
Despite a Buy rating and a higher price target, Visa's slight decline suggests short-term market fluctuations. The positive analyst outlook may support future gains.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80